January 11, 2022
C-Path’s ePRO Consortium Announces Rebranding, Changes Name to eCOA Consortium
Related Posts
-
C-Path Rare and Orphan Disease Conference Highlights Unprecedented Collaborations and Breakthroughs in Rare Disease Research -
Innovative Trial Design Approaches to Model Informed Drug Development in Rare and Neurological Diseases -
European Association of the Study of Diabetes Annual Meeting, C-Path T1D Consortium Presentation and Reception -
The CPP Consortium Welcomes Biohaven as its Newest Member -
C-Path and EATRIS Join Forces with New Collaboration Agreement